{"name": "Scil Proteins",
 "permalink": "scil-proteins",
 "crunchbase_url": "http://www.crunchbase.com/company/scil-proteins",
 "homepage_url": "http://www.scilproteins.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@scilproteins.com",
 "phone_number": "+49 (0) 345 27 99 63 30",
 "description": "",
 "created_at": "Thu Feb 03 04:46:16 UTC 2011",
 "updated_at": "Thu Feb 03 04:46:15 UTC 2011",
 "overview": "\u003Cp\u003EScil Proteins is a biopharmaceutical company discovering and developing Affilin\u00c2\u00ae molecules and working with industry partners in the development and manufacture of protein therapeutics and diagnostics. Affilin\u00c2\u00ae molecules are therapeutics and diagnostics based on a scaffold derived from the human protein Ubiquitin to form highly stable molecules with strong binding specificity and low immunogenicity. Scil Proteins\u00e2\u20ac\u2122 discovery platform is a fully patent protected screening technology for the identification of target-specific Affilin\u00c2\u00ae molecules using advanced selection systems. Scil Proteins has generated a pipeline of Affilin\u00c2\u00ae therapeutics targeting cancer and other therapeutic areas. It also offers the technology to the industry for collaborative discovery and development partnerships. With a longstanding expertise in protein production and development, Scil Proteins also offers GMP contract biomanufacturing and process development to biotech and pharma companies. Scil Proteins is a well-established private company located in Halle, Germany.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[88,
       70],
      "assets/images/resized/0012/0248/120248v1-max-150x150.jpg"],
     [[88,
       70],
      "assets/images/resized/0012/0248/120248v1-max-250x250.jpg"],
     [[88,
       70],
      "assets/images/resized/0012/0248/120248v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Ulrike",
      "last_name": "Fiedler",
      "permalink": "ulrike-fiedler",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Frank",
      "last_name": "Ubags",
      "permalink": "frank-ubags",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "\u20ac24M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.scilproteins.com/english/225/56/789001/liste9.html",
    "source_description": " Scil Proteins raises financing of \u00e2\u201a\u00ac24 Million",
    "raised_amount": 24000000.0,
    "raised_currency_code": "EUR",
    "funded_year": 2011,
    "funded_month": 2,
    "funded_day": 2,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "BioNet Holding",
         "permalink": "bionet-holding",
         "image":
          {"available_sizes":
            [[[113,
               42],
              "assets/images/resized/0027/0192/270192v1-max-150x150.png"],
             [[113,
               42],
              "assets/images/resized/0027/0192/270192v1-max-250x250.png"],
             [[113,
               42],
              "assets/images/resized/0027/0192/270192v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Heinrich-Damerow-Str. 1",
    "address2": "",
    "zip_code": "06120",
    "city": "Halle",
    "state_code": null,
    "country_code": "DEU",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}